← Back to Search

1 for Cardiovascular Disease (U-CHAMP Trial)

N/A
Waitlist Available
Led By Charlotte Jones, PhD, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

U-CHAMP Trial Summary

High blood pressure, elevated blood glucose and high cholesterol are related to the increased risk of stroke and heart disease. Many studies have shown that this risk can be significantly reduced by lowering blood pressure, blood glucose and cholesterol levels. Through a collaborative effort between Calgary Safeway pharmacists and Calgary Health Region family physician PCN's, U-CHAMP will deliver a program to assist in the identification and management of people with elevated blood pressure, blood glucose and cholesterol and through this effort, reduce the risk of heart disease and stroke in the urban Calgary population aged 18-85 years.

Eligible Conditions
  • Cardiovascular Disease
  • High Blood Sugar
  • High Blood Pressure
  • High Cholesterol

U-CHAMP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in systolic blood pressure between baseline (average of visits one and two) and program end (final visit).
Secondary outcome measures
Change in Framingham Global Cardiovascular Risk score (in those participants that do not have known vascular disease or diabetes and have a recorded baseline and end-of-study full lipid panel).
Proportion of individuals that have changes in drug therapy (new medication and/or dosage increase).
Proportion of individuals that obtain both a baseline and end of program full lipid panel
+2 more

U-CHAMP Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
referral to primary care network for management of blood pressure, lipids and diabetes.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,044 Total Patients Enrolled
University of AlbertaOTHER
889 Previous Clinical Trials
385,028 Total Patients Enrolled
Charlotte Jones, PhD, MDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
66 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
U-CHAMP: Urban Cardiovascular Health Assessment and Management Program
2008. "U-CHAMP: Urban Cardiovascular Health Assessment and Management Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00626041.
All > Health > Cardiovascular
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top